Pocketing $68M, PacBio Remains on Track for Commercial Launch — and Possible IPO — in 2010 | GenomeWeb

By Bernadette Toner

This article has been updated from a version posted on Aug. 13 to include additional information about the current financing environment for sequencing technology startups.

Pacific Biosciences said last week that it has raised $68 million in financing from a combination of new and existing investors, bringing its total VC financing to more than $260 million since it was founded in 2004.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.